Abstract:Highlights • Comp. 1 with dual-enzyme responsiveness can be controlled by microenvironment to realize accurate delivery of loaded therapeutic agents. • Functional components of Comp. 1 endow it with the ability to recognize tumor characteristics. • Combined chemotherapy and tumor-specific immunotherapy are used for precise therapy of highly invasive malignant tumors. Herein, we designed Comp. 1 to simultaneously respond to two enzymes: alkaline phosphatase and matrix metalloproteinase 2, which is commonly found in highly malignant cancer cell lines containing B16–F10 murine melanoma cells and CT26 murine colon carcinoma cells. We used the regional differences in the expression levels of dual-markers to accurately release immune molecule IND into tumor microenvironment for the activation of anti-tumor related immune effects, while in-situ self-assembly occurs. The dual-enzyme response process can further regulate the peptide precursors' self-assembly in the form of short rod-shaped nanofibers, enabling the delivery of the loaded chemotherapeutic drug HCPT into the cancer cells and further allowing the peptide assemblies to escape from lysosomes and return to cytoplasm in the form of tiny nanoparticles to induce apoptosis of cancer cells. This process does not occur in the single-positive breast cancer cell line MCF-7 or the normal hepatocytes cell line LO2, indicating the selectivity of the cancer cells exhibited using our strategy. In vivo studies revealed that Comp. 1 can effectively cooperate with chemotherapy to enhance the immunotherapy effect and induce immune responses associated with elevated pro-inflammatory cytokines in vivo to inhibit malignant tumors growth. Our dual-enzyme responsive chemo-immunotherapy strategy feasible in anti-tumor treatment, provides a new avenue for regulating peptide self-assembly to adapt to diverse tumor properties and may eventually be used for the development of novel multifunctional anti-tumor nanomedicines. Graphical abstract The dual-enzyme response process regulates the in situ self-assembly of peptide precursors to form nanofibers, simultaneously realizes the release of immune molecule IND in the tumor microenvironment, and delivers the loaded chemotherapeutic drug HCPT into cancer cells. After internalization, lysosomes escape is achieved and return to the cytoplasm in the form of tiny nanoparticles to induce apoptosis of cancer cells. This novel strategy has been demonstrated to be a powerful strategy for inhibiting the growth of malignant tumors. Download : Download high-res image (345KB) Download : Download full-size image

A Self-Assembled Peptide Nucleic Acid-Microrna Nanocomplex for Dual Modulation of Cancer-Related Micrornas

Multi-functional Peptide-MicroRNA Nanocomplex for Targeted MicroRNA Delivery and Function Imaging.

In Situ Amplification of Intracellular Microrna with Mnazyme Nanodevices for Multiplexed Imaging, Logic Operation, and Controlled Drug Release

A Smart Nano‐Theranostic Platform Based on Dual‐microRNAs Guided Self‐Feedback Tetrahedral Entropy‐Driven DNA Circuit

MicroRNA-Responsive DNA-Programmed Nanomedicine with Controllability of Cascaded Events for Cancer Therapy Enhancement

Self‐Adaptive Activation of DNAzyme Nanoassembly for Synergistically Combined Gene Therapy

A siRNA-Assisted Assembly Strategy to Simultaneously Suppress “Self” and Upregulate “Eat-Me” Signals for Nanoenabled Chemo-Immunotherapy

An intelligent DNA nanomachine for amplified MicroRNA imaging and MicroRNA-Guided efficient gene silencing

Self‐Assembly of Bidirectional‐Signal Nanoclusters for Two miRNAs Simultaneously Monitoring in Single Cancer Cells

A Janus 3D DNA nanomachine for simultaneous and sensitive fluorescence detection and imaging of dual microRNAs in cancer cells

Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model

Chemo-immunotherapy by dual-enzyme responsive peptide self-assembling abolish melanoma

A tumor-activatable peptide supramolecular nanoplatform for the delivery of dual-gene targeted siRNAs for drug-resistant cancer treatment

Rational Design of Microrna–sirna Chimeras for Multifunctional Target Suppression

Endogenous Protease-Activatable Nanosensor Based on PNA-Peptide-DNA Engineering for AND-Gated and Dual-Model Detection of MicroRNA in Single Living Tumor Cells

Endogenous microRNA triggered enzyme-free DNA logic self-assembly for amplified bioimaging and enhanced gene therapy via in situ generation of siRNAs

Activation of RIG‐I/MDA5 Signaling and Inhibition of CD47‐SIRPα Checkpoint with a Dual siRNA‐Assembled Nanoadjuvant for Robust Cancer Immunotherapy

Self-Assembly of a Multifunction DNA Tetrahedron for Effective Delivery of Aptamer PL1 and Pcsk9 siRNA Potentiate Immune Checkpoint Therapy for Colorectal Cancer

Self-assembly of Bi-Functional Peptides on Large-Pore Mesoporous Silica Nanoparticles for Mirna Binding and Delivery

A Dual Target-Recycling Amplification Strategy for Sensitive Detection of Micrornas Based on Duplex-Specific Nuclease and Catalytic Hairpin Assembly.

Engineering supramolecular dynamics of self-assembly and turnover of oncogenic microRNAs to drive their synergistic destruction in tumor models